mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
0.081 |
0.02 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.02 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.02 |
mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.02 |
mRNA |
DBeQ |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.02 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.02 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.02 |
mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.02 |
mRNA |
GSK269962A |
GDSC1000 |
pan-cancer |
AAC |
0.074 |
0.02 |
mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.02 |